Sex hormones and coronary disease: a review of the clinical studies.

作者: Marcia F. Kalin , Barnett Zumoff

DOI: 10.1016/0039-128X(90)90058-J

关键词: Internal medicinePopulationMedicineSex hormone-binding globulinMyocardial infarctionSex characteristicsEndocrinologyTestosteroneCoronary atherosclerosisMenopauseEstrogen

摘要: PIP: A male to female ration of coronary disease 2:1 has been a consistent finding. This differential persists event when the classic risk factors for disease--hypertension, smoking, obesity, diabetes, and hyperlipidemia--are controlled gender. The most likely ultimate cause this phenomenon is male-female differences in sex hormone patterns. Clinical studies area have either compared profiles men women with without or computed relative prevalence populations that differ their In general, research findings disputed hypothesis persons low levels protective factor such as estrogen progesterone high testosterone. Coronary patients actually elevated testosterone levels; endogenous are normal before infarction but show stress-mediated increase immediate postinfarction period. Findings premenopausal women, loss protection after menopause, cirrhosis-related hyperestrogenemia suggest natural estrogens antiatherogenic. effect pregnancy against myocardial infarction, despite concomitant potentially thrombogenic at time, seems indicate progesterone, whose also extremely during pregnancy, plays major anti-infarction distinct from estrogen. Studies oral contraceptive (OC) users taking brief periods found these exogenous hormones produce thrombosis not atherosclerosis. Finally, finding increased long-term OC indicates synthetic favor atherosclerosis by suppressing production.

参考文章(253)
W. H. W. Inman, M. P. Vessey, B. Westerholm, A. Engelund, Thromboembolic Disease and the Steroidal Content of Oral Contraceptives. A Report to the Committee on Safety of Drugs BMJ. ,vol. 2, pp. 203- 209 ,(1970) , 10.1136/BMJ.2.5703.203
Edward B. Waxier, Demetrios Kimbiris, Hans Van Den Broek, Bernard L. Segal, William Likoff, Myocardial infarction and oral contraceptive agents The American Journal of Cardiology. ,vol. 28, pp. 96- 101 ,(1971) , 10.1016/0002-9149(71)90039-7
PAUL D. WOOLF, ROBERT W. HAMILL, JOSEPH V. McDONALD, LOUYSE A. LEE, MARY KELLY, Transient Hypogonadotropic Hypogonadism Caused by Critical Illness The Journal of Clinical Endocrinology and Metabolism. ,vol. 60, pp. 444- 450 ,(1985) , 10.1210/JCEM-60-3-444
W. B. Kannel, Diabetes and cardiovascular disease. The Framingham study JAMA: The Journal of the American Medical Association. ,vol. 241, pp. 2035- 2038 ,(1979) , 10.1001/JAMA.241.19.2035
DAVID M. SPAIN, Sudden Death from Coronary Atherosclerosis A.M.A. Archives of Internal Medicine. ,vol. 100, pp. 228- 231 ,(1957) , 10.1001/ARCHINTE.1957.00260080054011
J I Mann, M P Vessey, M Thorogood, S R Doll, Myocardial infarction in young women with special reference to oral contraceptive practice. BMJ. ,vol. 2, pp. 241- 245 ,(1975) , 10.1136/BMJ.2.5965.241
R F Heller, H S Jacobs, A Vermeulen, J P Deslypere, Androgens, oestrogens, and coronary heart disease. BMJ. ,vol. 282, pp. 438- 439 ,(1981) , 10.1136/BMJ.282.6262.438
JAY M SULLIVAN, ROGER VANDER ZWAAG, GEORGE F LEMP, JEFF P HUGHES, VIRGINIA MADDOCK, FRANK W KROETZ, KB Ramanathan, DAVID M MIRVIS, Postmenopausal Estrogen Use and Coronary Atherosclerosis Annals of Internal Medicine. ,vol. 108, pp. 358- 363 ,(1988) , 10.7326/0003-4819-108-3-358
Gerald B. Phillips, William P. Castelli, Robert D. Abbott, Patricia M. McNamara, Association of hyperestrogenemia and coronary heart disease in men in the Framingham cohort The American Journal of Medicine. ,vol. 74, pp. 863- 869 ,(1983) , 10.1016/0002-9343(83)91078-1
Sidney Pell, MYOCARDIAL INFARCTION IN A ONE-YEAR INDUSTRIAL STUDY Journal of the American Medical Association. ,vol. 166, pp. 332- 337 ,(1958) , 10.1001/JAMA.1958.02990040018004